← FDA Drug Approvals (Drugs@FDA)

LIRAGLUTIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BIOCON PHARMA · Approved 2026-03-11

Drug application

FDA Application #

ANDA215245

Application type

Abbreviated New Drug Application (Generic)

Brand name

LIRAGLUTIDE

Generic name

LIRAGLUTIDE

Active ingredients

LIRAGLUTIDE

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

BIOCON PHARMA

Manufacturer

Biocon Pharma Inc.

First approval

2026-03-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown